SCHEMBL5269328

SCHEMBL5269328

COC(=O)c1cc(-c2cc[nH]c2)n(-c2ccc(Cl)nn2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
ALOX5 P09917 3/20 0.39
PTGS2 P35354 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.36
MALT1 Q9UDY8 3/20 0.35
RXRA P19793 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
MMP14 P50281 1/20 0.35
RAB9A P51151 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
RPA1 P27694 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272583 0.83 SMN1; SMN2 (0.42) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5266533 0.83 SMN1; SMN2 (0.41) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL2910701 0.81 SMN1; SMN2 (0.47) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5269292 0.81 SMN1; SMN2 (0.44) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5267517 0.77 RPA1 (0.46) SMN1; SMN2MEN1KMT2ARPA1
SCHEMBL2917351 0.77 SLC16A3 (0.40) SMN1; SMN2MEN1KMT2AFAAHMGLL
SCHEMBL5268843 0.77 SMN1; SMN2 (0.38) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5522528 0.76 ALOX5 (0.40) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5266028 0.76 RAB9A (0.39) SMN1; SMN2ALOX5PTGS2MEN1KMT2A
SCHEMBL5269426 0.76 SMN1; SMN2 (0.38) SMN1; SMN2ALOX5PTGS2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
CN-101001852-A Pyrazole derivatives DAIICHI SEIYAKU CO (JP) 2007-07-18 CN disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 SMN1; SMN2 3490/4885ALOX5 94/4885PTGS2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.